Azenta 对比 Bio-Techne
可添加、更换或移除公司，最多四家。
简而言之
- Bio-Techne 规模更大:2026 财年营收 $1.2B，Azenta 为 $594M，约为后者的 2.0 倍。
- Azenta 营收增长更快(3.6%，对方为 −0.4%)。
- Bio-Techne 每一美元销售额中留下的营业利润更多(营业利润率 20.7%，对方为 −4.5%)。
- Bio-Techne 将更多销售额转化为自由现金流(自由现金流利润率 21.7%，对方为 6.5%)。
| 最近财年 | AZTA · FY25 | TECH · FY26 |
|---|---|---|
| 规模 | ||
| 市值 | $1.7B | $11.4B |
| 营收 | $594M | $1.2B |
| 自由现金流 | $38.3M | $263M |
| 净利润 | −$55.8M | $182M |
| 增长 | ||
| 营收增长 | 3.6% | −0.4% |
| 5年增长率 | 8.9% | 5.5% |
| 股数变化 | −13.7% | −1.7% |
| 盈利能力 | ||
| 毛利率 | 45.5% | 65.8% |
| 营业利润率 | −4.5% | 20.7% |
| 净利率 | −9.4% | 15.0% |
| 自由现金流利润率 | 6.5% | 21.7% |
| 资本回报率 | — | 9.2% |
| 股本回报率 | −3.2% | 9.0% |
| 资产负债表 | ||
| 净债务 | — | −$64.7M |
| 净债务 / EBITDA | — | −0.2x |
| 股息与回购 | $0.0M | $91.6M |
| 估值与质量 | ||
| 市盈率 | — | — |
| Piotroski F 分数 | — | 9 |
FY17
AZTA $528M
TECH $563M
FY18
AZTA $632M
TECH $643M
FY19
AZTA $334M
TECH $714M
FY20
AZTA $389M
TECH $739M
FY21
AZTA $514M
TECH $931M
FY22
AZTA $556M
TECH $1.1B
FY23
AZTA $552M
TECH $1.1B
FY24
AZTA $573M
TECH $1.2B
FY25
AZTA $594M
TECH $1.2B
FY26
AZTA —
TECH $1.2B
AZTA
TECH
FY17
AZTA 2.7%
TECH 21.4%
FY18
AZTA 5.0%
TECH 21.2%
FY19
AZTA −14.2%
TECH 20.6%
FY20
AZTA −9.4%
TECH 21.3%
FY21
AZTA −6.1%
TECH 25.5%
FY22
AZTA −4.5%
TECH 26.8%
FY23
AZTA −11.1%
TECH 26.3%
FY24
AZTA −8.9%
TECH 17.8%
FY25
AZTA −4.5%
TECH 8.4%
FY26
AZTA —
TECH 20.7%
AZTA
TECH
FY17
AZTA $83.6M
TECH $129M
FY18
AZTA $61.2M
TECH $149M
FY19
AZTA $67.0M
TECH $156M
FY20
AZTA −$2.1M
TECH $153M
FY21
AZTA $97.1M
TECH $308M
FY22
AZTA −$539M
TECH $280M
FY23
AZTA −$33.6M
TECH $216M
FY24
AZTA $12.4M
TECH $236M
FY25
AZTA $38.3M
TECH $257M
FY26
AZTA —
TECH $263M
AZTA
TECH
FY17
AZTA —
TECH 7.8%
FY18
AZTA —
TECH 10.9%
FY19
AZTA −4.8%
TECH 8.8%
FY20
AZTA −3.0%
TECH 8.3%
FY21
AZTA −2.3%
TECH 13.7%
FY22
AZTA —
TECH 15.3%
FY23
AZTA —
TECH 13.2%
FY24
AZTA —
TECH 8.6%
FY25
AZTA —
TECH 3.5%
FY26
AZTA —
TECH 9.2%
AZTA
TECH
各公司最近一个财年的数据；各公司财年结束月份不同。在越高(或越低)明显越好的行中，突出显示最佳值。不构成投资建议。